https://pharminent.com/sanofi-and-regeneron-expand-immunology-alliance-in-8b-deal/ 2026-10-01T11:45:59Z Pharminent en Sanofi and Regeneron expand immunology alliance in $8B deal 2026-10-01T11:45:59Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-september-30-2026/ 2026-10-01T02:51:07Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • September 30, 2026 2026-10-01T02:51:07Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-september-30-2026/ 2026-10-01T02:50:52Z Pharminent en Manufacturing Intelligence • Weekly Digest • September 30, 2026 2026-10-01T02:50:52Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-september-29-2026/ 2026-09-30T20:37:46Z Pharminent en Oncology Intelligence Digest • September 29, 2026 2026-09-30T20:37:46Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-september-30-2026/ 2026-09-30T15:07:22Z Pharminent en Strategic News Watch • September 30, 2026 2026-09-30T15:07:22Z Blog https://pharminent.com/novo-to-pay-hengrui-up-to-2-6b-for-once-weekly-obesity-pill/ 2026-09-30T11:45:53Z Pharminent en Novo to pay Hengrui up to $2.6B for once-weekly obesity pill 2026-09-30T11:45:53Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-september-29-2026/ 2026-09-29T14:53:24Z Pharminent en Strategic News Watch • September 29, 2026 2026-09-29T14:53:24Z Blog https://pharminent.com/astrazeneca-takes-10-summit-stake-in-2b-deal/ 2026-09-29T11:45:53Z Pharminent en AstraZeneca takes 10% Summit stake in $2B deal 2026-09-29T11:45:53Z Blog